Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management (Q28272063)

Europe PubMed Central

title

Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management (English)

1 reference

https://doi.org/10.1016%2FS1353-8020%2809%2970847-8

25 March 2017

1 reference

Daniela Frosini

2

0 references

Ubaldo Bonuccelli

object named as

Ubaldo Bonuccelli

series ordinal

4

0 references

Roberto Ceravolo

object named as

Roberto Ceravolo

series ordinal

1

0 references

author name string

Carlo Rossi

series ordinal

3

1 reference

https://doi.org/10.1016%2FS1353-8020%2809%2970847-8

25 March 2017

language of work or name

English

0 references

publication date

December 2009

1 reference

https://doi.org/10.1016%2FS1353-8020%2809%2970847-8

Parkinsonism and Related Disorders

25 March 2017

published in

1 reference

https://doi.org/10.1016%2FS1353-8020%2809%2970847-8

25 March 2017

volume

15 Suppl 4

0 references

15

1 reference

https://doi.org/10.1016%2FS1353-8020%2809%2970847-8

25 March 2017

page(s)

S111-5

0 references

S111-S115

1 reference

https://doi.org/10.1016%2FS1353-8020%2809%2970847-8

Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome

25 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

'Behavioral' addictions: do they exist?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Pathological gambling: focusing on the addiction, not the activity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

The neurobiology and genetics of impulse control disorders: relationships to drug addictions

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Pathological gambling associated with dopamine agonist therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Gambling and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Problematic gambling on dopamine agonists: Not such a rarity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Prospective prevalence of pathologic gambling and medication association in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Association of dopamine agonist use with impulse control disorders in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

The relationship between impulsivity and impulse control disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Prevalence of problem and pathological gambling in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Prevalence of pathological gambling in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Serial cognitive profiles in levodopa-induced hypersexuality

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Hypersexuality with Antiparkinsonian Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Apomorphine-induced penile erections in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Clinical features associated with impulse control disorders in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Pathological gambling caused by drugs used to treat Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Pathological gambling is linked to reduced activation of the mesolimbic reward system

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Compulsive drug use linked to sensitized ventral striatal dopamine transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Functional abnormalities underlying pathological gambling in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Long-term follow-up of impulse control disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Disabling repetitive behaviors in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Possible zoophilia associated with dopaminergic therapy in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Pathologic gambling in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Impulse control disorders: clinical characteristics and pharmacological management

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970847-8

7 January 2021

10.1016/S1353-8020(09)70847-8

Identifiers

DOI

1 reference

https://doi.org/10.1016%2FS1353-8020%2809%2970847-8